nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse reactions in selected patients following intravenous infusions of gamma globulin
|
Day, N.K. |
|
1984 |
76 |
3P1 |
p. 25-32 8 p. |
artikel |
2 |
Antibody levels in reduced/alkylated intravenous immune globulin
|
Rousell, Ralph H |
|
1984 |
76 |
3P1 |
p. 40-45 6 p. |
artikel |
3 |
A preparation of modified immune serum globulin (human) suitable for intravenous administration
|
Schroeder, Duane D. |
|
1984 |
76 |
3P1 |
p. 33-39 7 p. |
artikel |
4 |
Comparative anti-pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo
|
Collins, Michael S. |
|
1984 |
76 |
3P1 |
p. 155-160 6 p. |
artikel |
5 |
Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens
|
Hill, Harry R |
|
1984 |
76 |
3P1 |
p. 61-66 6 p. |
artikel |
6 |
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
|
Ochs, Hans D. |
|
1984 |
76 |
3P1 |
p. 78-82 5 p. |
artikel |
7 |
Complement interaction with immune serum globulin and immune globulin intravenous
|
Bing, David H. |
|
1984 |
76 |
3P1 |
p. 19-24 6 p. |
artikel |
8 |
Discussion
|
|
|
1984 |
76 |
3P1 |
p. 219-231 13 p. |
artikel |
9 |
Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes
|
Sorensen, Ricardo U. |
|
1984 |
76 |
3P1 |
p. 83-90 8 p. |
artikel |
10 |
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa
|
Holder, Ian Alan |
|
1984 |
76 |
3P1 |
p. 161-167 7 p. |
artikel |
11 |
High-dose intravenous gamma globulin to suppress alloimmune destruction of donor platelets
|
Junghans, Richard P |
|
1984 |
76 |
3P1 |
p. 204-208 5 p. |
artikel |
12 |
Immunoglobulin G (IgG) subclasses and human disease
|
Oxelius, Vivi-Anne |
|
1984 |
76 |
3P1 |
p. 7-18 12 p. |
artikel |
13 |
Immunologic response of trauma and burns
|
Munster, Andrew M |
|
1984 |
76 |
3P1 |
p. 142-145 4 p. |
artikel |
14 |
Improved response of patients refractory to random-donor platelet transfusions by intravenous gamma globulin
|
Kekomäki, Riitta |
|
1984 |
76 |
3P1 |
p. 199-203 5 p. |
artikel |
15 |
Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults
|
Oral, Arsinur |
|
1984 |
76 |
3P1 |
p. 187-192 6 p. |
artikel |
16 |
Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children
|
Warrier, Indira |
|
1984 |
76 |
3P1 |
p. 193-198 6 p. |
artikel |
17 |
Intravenous immune globulin therapy in hypogammaglobulinemia
|
Pirofsky, Bernard |
|
1984 |
76 |
3P1 |
p. 53-60 8 p. |
artikel |
18 |
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura
|
Carroll, Robert R |
|
1984 |
76 |
3P1 |
p. 181-186 6 p. |
artikel |
19 |
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation
|
Winston, Drew J. |
|
1984 |
76 |
3P1 |
p. 128-133 6 p. |
artikel |
20 |
Intravenous immunoglobulin in neonatal group B streptococcal disease
|
Fischer, Gerald W |
|
1984 |
76 |
3P1 |
p. 117-123 7 p. |
artikel |
21 |
Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin
|
Pizzo, Philip A |
|
1984 |
76 |
3P1 |
p. 101-110 10 p. |
artikel |
22 |
Opportunistic infections in severely burned patients
|
Pruitt Jr., Basil A. |
|
1984 |
76 |
3P1 |
p. 146-154 9 p. |
artikel |
23 |
Phase I study of intravenous gamma globulin in multiple myeloma
|
Gordon, David S |
|
1984 |
76 |
3P1 |
p. 111-116 6 p. |
artikel |
24 |
Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin
|
Condie, Richard M. |
|
1984 |
76 |
3P1 |
p. 134-141 8 p. |
artikel |
25 |
Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states
|
Montanaro, Anthony |
|
1984 |
76 |
3P1 |
p. 67-72 6 p. |
artikel |
26 |
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa
|
Collins, Michael S. |
|
1984 |
76 |
3P1 |
p. 168-174 7 p. |
artikel |
27 |
Replacement therapy with modified immunoglobulin G in burn patients: Preliminary kinetic studies
|
Shirani, Khan Z. |
|
1984 |
76 |
3P1 |
p. 175-180 6 p. |
artikel |
28 |
Significance of immunoglobulin G subclasses
|
Heiner, Douglas C |
|
1984 |
76 |
3P1 |
p. 1-6 6 p. |
artikel |
29 |
Synergy between acylureidopenicillins and immunoglobulin G in experimental animals
|
Dalhoff, Axel |
|
1984 |
76 |
3P1 |
p. 91-100 10 p. |
artikel |
30 |
Thirty years of supplying the missing link
|
M. Dwyer, John |
|
1984 |
76 |
3P1 |
p. 46-52 7 p. |
artikel |
31 |
Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia
|
Sorensen, Ricardo U. |
|
1984 |
76 |
3P1 |
p. 73-77 5 p. |
artikel |
32 |
Use of intravenous immunoglobulin in chronic lymphocytic leukemia
|
Besa, Emmanuel C. |
|
1984 |
76 |
3P1 |
p. 209-218 10 p. |
artikel |
33 |
Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin
|
Paryani, Sharon G. |
|
1984 |
76 |
3P1 |
p. 124-127 4 p. |
artikel |